Acenocoumarol induced intra cerebral haemorrhage

Jyotsna Allamsetty; Syam Prashanth Pedada; Hari Krishna Allu; V.Nagaraju G

doi:10.37022/jpmhs.v3i1.14

Authors

Jyotsna Allamsetty Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences, Near Tagarapuvalasa Bridge,Vizayanaragam,AP,India
Syam Prashanth Pedada Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences, Near Tagarapuvalasa Bridge,Vizayanaragam,AP,India
Dr. Allu Hari Krishna Associate professor, Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences, Near Tagarapuvalasa Bridge,Vizayanaragam,AP,India
Dr.G.V.Nagaraju Assistant Professor, Department of Pharmacy Practice, QIS College of Pharmacy, Ongole, AP, India.

DOI:

https://doi.org/10.37022/jpmhs.v3i1.14

Keywords:

Oral anti-coagulation therapy, Intra cerebral hemorrhage, Chronic rheumatic heart disease, Mitral valve stenosis

Abstract

Life threatening intra cerebral haemorrhage (ICH) is the most serious complication of oral anti-coagulation therapy (OAT) with mortality in excess of 50%.early intervention focuses on rapid correction of coagulopathy in order to prevent continued bleeding. Although management guidelines for such haemorrhages are available for the older generation anticoagulants, they are still lacking for newer agents, which are becoming popular among physicians. Supportive care, including blood pressure control, and reversal of anticoagulation remain the cornerstone of acute management of AICH. A case report of young lady of age 29yrs old came with chief compliant of headache, vomiting and involuntary maturation, sudden loss of vision both eyes .she had history of CRHD(chronic rheumatic heart disease) with severe mitral valve stenosis and of post Operative MVR(mitral valve replacement). Altered sensorium after surgery .past medication history was using Acenocoumarol (acenocoumaral) 3mg for 15 days .while observing the patient. Patient was irritable nd abdomen was soft, neck was stiff. Acenocoumarol has been induced intra cerebral haemorrhage in patient and also lead to sub dural haemorrhage infract temporal parietal region

Downloads

Download data is not yet available.

References

Van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid hemorrhage. Lancet 2007; 369:306-18.

Sudlow CL, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 1997; 28:491-9.

Foelholm R, Waltimo O. Epidemiology of chronic subdural haematoma. Acta Neurochir 1975; 32:247-50.

Hamlat A, Mazzon A, Adn M, et al. Intracranial epidural haematomas in elderly patients: observations in 14 patients. Acta Neurochir 2005; 147: 1055-60; discussion 1060.

Qureshi AI, Mendelow AD, Hanley DF. Intracerebral hemorrhage. Lancet 2009; 373: 1632-44.

Kleindorfer D, Broderick J, Khoury J, et al. The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke; a journal of cerebral circulation 2006; 37: 2473-8.

Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 1991; 84:527-39.

van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002; 288:2441-8.

Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131: 492-501.

Flaherty ML, Kissela B, Woo D, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 2007; 68: 116-21.

Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage.Facts and hypotheses. Stroke 1995; 26: 1471-7.

Ammollo CT, Semeraro F, Incampo F, Semeraro N, Colucci M: Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor. J Thromb Haemost 2010, 8:790–798.

Neyens R, Bohm N, Cearley M, Andrews C, Chalela J: Dabigatran-associated subdural hemorrhage: using thromboelastography (TEG) to guide decision-making. J Thromb Thrombolysis 2014, 37:80–83.

Yuan S, Ferrell C, Chandler WL: Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thromb Res 2007, 120:29–37.

Selim MH, Molina CA: The role of hemostatic therapy in anticoagulationas.

Tripodi A: The laboratory and the new oral anticoagulants. Clin Chem 2013,59:353–362.

Guyatt GH, Norris SL, Schulman S, Hirsh J, Eckman MH, Akl EA, Crowther M,Vandvik PO, Eikelboom JW, McDonagh MS, Lewis SZ, Gutterman DD, Cook DJ,Schunermann HJ: Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based ClinicalPractice Guidelines. Chest 2012, 141:53S–70S.

Steiner T, Bohm M, Dichgans M, Diener HC, Ell C, Endres M, Epple C, Grond M,Laufs U, Nickenig G, Reiss H, Rother J, Schellinger PD, Spannagl M, Veltkamp R:Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.Clin Res Cardiol 2013, 102:399–412.